ReviewMolecular cancer2022
Targeting KRAS mutant cancers: from druggable therapy to drug resistance.
Chunxiao Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
138 papers cite itlatest 60 shown
this paperpooled ittrialcites it